GCG and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: A study evaluated the effect of a GLP1 agonist (Exenatide) in five SBS patients with ≤ 90 cm of small bowel and clinical evidence of nutritional deprivation.